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contraction during and after potassium cardioplegic
infusion is in part associated with opening of adenosine
triphosphate–activated potassium channels (K+ATP chan-
nels) and calcium accumulation in the coronary vascular
smooth muscle.1,2 The inhibition of accumulation of
[Ca2+]i and maintenance of ATP tissue concentration
with magnesium or other substances may theoretically
favor a magnesium-based or blood-based cardioplegic
solution.3 Because the addition of blood to potassium
cardioplegic solution4 and magnesium cardioplegic
solution2 have similar effects in preserving b -adrenergic
and endothelium-dependent relaxation and myogenic
contraction, all of which are important in blood flow
regulation, it was hypothesized that the addition of blood
or Mg2+ to a hyperkalemic crystalloid cardioplegic solu-
tion could prevent functional damage to the vascular
I ntracellular calcium [Ca2+]i accumulation in coronarysmooth muscle cells is associated with derangements
in coronary vasomotor tone and contractility after
ischemic cardioplegic infusion. The altered myogenic
Objective: The effects of magnesium- and potassium-based crystalloid
and blood-containing cardioplegic solutions on coronary smooth muscle
intracellular free calcium ([Ca2+]i) accumulation and microvascular
contractile function were examined. Methods: Isolated ferret hearts were
subjected to hyperkalemic (25 mmol/L K+) blood cardioplegic infusion,
hypermagnesemic (25 mmol/L Mg2+, K+-free) crystalloid cardioplegic
infusion, or hyperkalemic crystalloid cardioplegic infusion for 1 hour.
Coronary arterioles were isolated, cannulated, and loaded with fura 2.
Reactivity and [Ca2+]i were assessed with videomicroscopy. [Ca2+]i was
measured at baseline and after application of 50 mmol/L KCl. In addi-
tion, [Ca2+]i and vascular contraction were measured during exposure to
Mg2+ and K+ cardioplegic solution at both 4°C and 37°C. Results: From
a baseline [Ca2+]i of 177 ± 52 nmol/L, K+ cardioplegic infusion (302 ± 80
nmol/L potassium) markedly increased [Ca2+]i, whereas blood cardio-
plegic infusion (214 ± 53 nmol/L) and Mg2+ cardioplegic infusion (180 ±
42 nmol/L) did not alter [Ca2+]i. Although a difference between groups
in percentage contraction after application of 50 mmol/L KCl was not
observed, [Ca2+]i increased significantly more in vessels in the control
group (764 ± 327 nmol/L) and the K+ crystalloid cardioplegic infusion
group (698 ± 215 nmol/L) than in vessels in the blood cardioplegic infu-
sion group (402 ± 45 nmol/L) and the Mg2+ cardioplegic infusion group
(389 ± 80 nmol/L). Mg2+ cardioplegic solution induced no microvascular
contraction at either 4°C or 37°C, nor was an increase in [Ca2+]i
observed. K+ cardioplegic solution induced microvascular contraction
at 37°C but not at 4°C; it increased [Ca2+]i at both 4°C and 37°C.
Conclusion: An Mg2+-based cardioplegic solution, or appropriate Mg2+
or blood supplementation of a K+ crystalloid cardioplegic solution, may
decrease the accumulation of [Ca2+]i in the vascular smooth muscle dur-
ing ischemic arrest. (J Thorac Cardiovasc Surg 1999;118:163-72)
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INTRACELLULAR FREE CALCIUM ACCUMULATION IN FERRET VASCULAR SMOOTH MUSCLE 
DURING CRYSTALLOID AND BLOOD CARDIOPLEGIC INFUSIONS
system caused by increased [Ca2+]i accumulation in the
coronary smooth muscle. In this study [Ca2+]i accumu-
lation in the coronary vascular smooth muscle and
microvascular contraction were examined during
ischemic arrest with a cold hyperkalemic blood cardio-
plegic solution, a hyperkalemic crystalloid cardioplegic
solution, or a magnesium-based cardioplegic solution.
Because the coronary microcirculation is the primary
site of regulation of myocardial perfusion, microvascu-
lar tissue was examined.
Materials and methods
Male ferrets (8-12 weeks of age) were anesthetized with
chloroform in a ventilation hood. The hearts were removed
after injection of a small amount of heparin and were imme-
diately immersed in a cold (4°C) saline solution. The follow-
ing procedures were immediately undertaken.
Crystalloid cardioplegic infusion groups. After the can-
nulation of the ascending aortic root of isolated ferret hearts
with a small catheter, 20 mL cold (4°C) Ca2+-free hypermag-
nesemic crystalloid cardioplegic solution (25 mmol/L Mg2+,
n = 6) or cold Ca2+-free hyperkalemic crystalloid cardioplegic
solution (25 mmol/L K+, n = 6) was infused into the coronary
arteries through the aorta at a pressure of approximately 40
mm Hg. The composition of the Mg2+ cold crystalloid car-
dioplegic solution was as follows (in millimoles per liter):
121.0 NaCl, 25.0 MgCl2, 4.7 KCl, 12.0 NaHCO3, and 11.1
glucose in purified water. K+ cold crystalloid cardioplegic
solution had the following composition (in millimoles per
liter): 121.0 NaCl, 25.0 KCl, 12.0 NaHCO3, and 11.1 mmol/L
glucose in purified water. In both groups saline solution slush
was placed on the surface of the heart to provide topical
hypothermia during the ischemic period. Infusion of the car-
dioplegic solution (10 mL) in each group was repeated at 20-
minute intervals for a total arrest time of 60 minutes (2 addi-
tional doses). The heart was then immediately placed in a
cold Krebs buffer solution of the following composition (in
millimoles per liter): 118.3 NaCl, 4.7 KCl, 2.5 CaCl2, 1.2
MgSO4, 1.2 NaH2PO4, 25.0 NaHCO3, and 11.1 glucose in
purified water.
Blood cardioplegic infusion group. In 6 isolated ferret
hearts, 20 mL hyperkalemic cold blood cardioplegic solution
(4:1 mixture of oxygenated blood with high-potassium crys-
talloid cardioplegic solution resulting in 25 mmol/L KCl) was
infused into the aortic root as described above previously, fol-
lowed by intermittent infusion of 10 mL low-potassium cold
blood cardioplegic solution (4:1 mixture of oxygenated blood
with low-potassium crystalloid cardioplegic solution result-
ing in 12.5 mmol/L KCl) every 20 minutes (K+ blood cardio-
plegic infusion group). The compositions of the high- and
low-potassium solutions used in this study to create the blood
cardioplegic solutions contained 60 or 30 mmol/L KCl,
respectively, 12.5 g mannitol, 50 mL citrate-phosphate-dex-
trose solution and 10 mEq tris(hydroxymethyl)aminomethane
in 500 mL of 5% dextrose and 0.225% saline solution. In all
groups, after 60 minutes of cardioplegic arrest the heart was
immediately placed in a cold Krebs buffer solution.
Cold global ischemia group. In another 6 experiments
isolated ferret hearts were flushed with cold Krebs buffer
solution, placed in a cold saline solution for 60 minutes (cold
global ischemia group) and then placed in a cold Krebs buffer
solution.
Animal care. All animals received humane care in compli-
ance with the Boston Biomedical Research Institute
Committee on Animal Research and the “Guide for the Care
and Use of Laboratory Animals” prepared by the Institute of
Laboratory Animal Resources and published by the National
Institute of Health (NIH Publication No. 86-23, revised 1985).
Responses of nonischemic vessels. Microvessels were
immediately obtained from nonischemic ferret hearts, cannulat-
ed as described previously, and then loaded with fura 2. Vessels
were exposed to either Mg2+ cold crystalloid cardioplegic solu-
tion, Mg2+ cold crystalloid cardioplegic solution supplement-
ed with 1.0 mmol/L Ca2+ cold crystalloid cardioplegic solu-
tion, K+ cold crystalloid cardioplegic solution supplemented
with 1.0 mmol/L Ca2+, or K+ cold crystalloid cardioplegic solu-
tion supplemented with 1.0 mmol/L Mg2+ at either 4°C or 37°C
(n = 4-5 hearts/group) for 5 to 10 minutes. The fluorescence and
contraction responses were then measured.
Coronary microvessel preparations. After ischemic car-
dioplegic interventions, coronary arterioles (mean 133 ± 8
m m in internal diameter, ranging from 100 to 150 m m) were
immediately dissected from the left anterior descending coro-
nary artery–dependent subepicardial region of the free wall of
the left ventricle with a · 10 to · 60 dissecting microscope
(Olympus Optical Co, Ltd, Tokyo, Japan). The vessels were
placed in a microvessel chamber (University of Iowa Medical
Instrumentation, Iowa City, Iowa), cannulated with dual glass
micropipettes measuring 40 to 80 m m in diameter, and
secured with 10-0 nylon monofilament suture (Ethicon, Inc,
Somerville, NJ). Oxygenated (95% oxygen and 5% carbon
dioxide) Krebs buffer solution warmed to 37°C was continu-
ously circulated through the microvessel chamber. Vessels
were pressurized to 40 mm Hg in a no-flow state by means of
a burette manometer filled with a Krebs buffer solution. With
an inverted microscope (Zeiss IM 35, · 40-200; Carl Zeiss,
Inc, Thornwood, NY) connected to a camera (Hitachi model
KP 115; Hitachi Denshi America, Ltd, Woodbury, NY), the
microvessel image was projected onto a black and white tele-
vision monitor. The microvessels were allowed to bathe in the
chamber for at least 30 minutes before internal lumen diam-
eter and [Ca2+]i measurements were taken at baseline and
under various conditions.
Coronary smooth muscle [Ca2+]i handling and concen-
tration. Vascular smooth muscle [Ca2+]i was measured in
isolated single coronary microvessels as previously reported
by Meininger and colleagues.5 In K+ blood cardioplegic infu-
sion, Mg2+ cold crystalloid cardioplegic infusion, K+ cold
crystalloid cardioplegic infusion, and cold global ischemia
groups, after equilibration of the microvessels, fura 2 was
loaded into the microvessels with a noncirculating Krebs
solution containing 5 m mol/L fura 2 AM, which was dis-
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solved in 0.05% dimethyl sulfoxide and 0.01% pluronic acid
at room temperature (22°C-25°C), for 45 minutes. At the end
of the loading period the extracellular fura 2 AM was washed
out with Krebs solution and at least 30 minutes was allowed
for de-esterification of intracellular fura 2 AM at 37°C. Fura
2 signals from the microvessels were recorded by positioning
the pinhole on the lowest and most homogeneous location of
the microvessel wall with a Nikon Fluor · 40 (NA 0.8; Nikon
Corporation, Tokyo, Japan) objective. To minimize bleaching
and cell damage, the shutter was opened only when necessary
for taking measurements. Excitation interference filters at
350 ± 5 nm and 390 ± 6 nm were used.
A computer-controlled filter wheel produced by Ludl
switches filtered every 2 msec. Fluorescent signals were col-
lected with a photomultiplier tube (Hamamatsu R928;
Hamamatsu Photonics KK, Hananatsu City, Japan) after
excitation at 350 nm and 390 nm. The signals at the 2 wave-
lengths from the photomultiplier tube were digitized by a
Data Acquisition-EZ A/D Converter and processed using a
DTVee program version 3.0 (Data Translation, Inc, Marlboro,
Mass). The background signals at the 2 wavelengths were
measured to subtract from subsequent fluorescent signal
measurements. Baseline and KCl-induced (50 mmol/L)
[Ca2+]i changes in fluorescence at 350 and 390 nm were
recorded at steady-state at the same time that the respective
contraction responses were observed. A 50-mmol/L KCl con-
centration was chosen to induce an increase in [Ca2+]i.
Measurements were made and recorded 3 to 5 minutes after
the drug administration, when the response had stabilized.
The microvessels were washed with Krebs buffer solution at
37°C and allowed to equilibrate in a drug-free Krebs buffer
solution for 20 minutes between interventions. Comparisons
were made against the responses of microvessels and [Ca2+]i
from instrument-free control hearts.
Absolute ([Ca+2]i) was calculated as follows:
[Ca+2]i = Kd · [(R – Rmin)/(Rmax – R)] · S
where Kd was the dissociation constant; R was the ratio of the
smooth muscle signal at 350 nm to that at 390 nm; Rmax was
determined after treating microvessels with 50 m mol/L 4-
bromo-A23187 containing 150 mmol/L KCl, 1 mmol/L Ca2+,
and 5 mmol/L piperazine-N-N´-bis (2-ethanesulfonic acid)
(PIPES); Rmin was determined after treating microvessels
with 4 mmol/L ethyleneglycol-bis-( b -aminoethylether)-
N,N,N´,N´-tetraacetic acid; and S was the ratio of the 390 nm
signal in microvessels treated with ethyleneglycol-bis-(b -
aminoethylether)-N,N,N´,N´-tetraacetic acid to that in the
presence of 4-bromo-A23187. A Kd value of 240 nmol/L at
37°C was used. The increase in absolute [Ca2+]i was
expressed as percentage change from baseline [Ca2+]i (100%
· given [Ca2+]i/baseline [Ca2+]I). 
Drugs. Fura 2 AM was obtained from Molecular Probes
(Molecular Probes, Inc, Eugene, Ore). The 4-bromo-A23187
and dimethyl sulfoxide were Calbiochem brand (CN
Biosciences, Inc, San Diego, Calif). Ethyleneglycol-bis-(b -
aminoethylether)-N,N,N´,N´-tetraacetic acid, PIPES, magne-
sium chloride and pluronic acid were obtained from Sigma
(Sigma, St Louis, Mo). KCl were obtained from Fisher
Scientific (Fisher Scientific Worldwide, Laboratory Projects
Division, Springfield, NJ). Pluronic acid was dissolved in
dimethyl sulfoxide to make a stock solution that was stored at
–20°C. Fura 2 AM solution was prepared on the day of the
study. Other drugs were dissolved in ultrapure distilled water.
Statistical analysis. The contraction responses were
expressed as the percentage contraction of the initial diame-
ter of the microvessels. A negative value denoted relaxation
response. All data were expressed as mean ± SD. Analysis of
variance followed by the Fisher exact test was used to com-
pare changes in percentage increase or absolute change in
[Ca2+]i between groups or to compare percentage vascular
contraction between groups. Depending on the number of
multiple comparisons performed, the Bonferroni correction
was used to correct for multiple comparisons.
Results
Effects of ischemic cardioplegic infusion. Although
exposure of microvessels to cold K+ crystalloid cardio-
plegic solution or cold global ischemia significantly
increased [Ca2+]i, exposure to cold K+ blood cardio-
plegic solution or cold Mg2+ crystalloid cardioplegic
solution did not increase [Ca2+]I (Fig 1). These changes
in [Ca2+]i were not completely reversible after repeti-
tive washing with Krebs buffer solution at 37°C (data
not shown).
No differences in percentage contraction were
observed between groups after application of 50
mmol/L KCl (Fig 2). However, [Ca2+]i in absolute
terms increased significantly more in control vessels
(764 ± 327 nmol/L) and vessels in the K+ cold crystal-
loid cardioplegic infusion group (698 ± 215 nmol/L)
than in microvessels in the K+ blood cardioplegic infu-
sion group (402 ± 45 nmol/L, P =.04 versus K+ cold
crystalloid cardioplegic infusion), Mg2+ cold crystal-
loid cardioplegic infusion (389 ± 80 nmol/L, P =.02
versus K+ cold crystalloid cardioplegic infusion), and
cold global ischemia (580 ± 110 nmol/L) groups. In
terms relative to the baseline concentration, changes in
[Ca2+]i induced by 50 mmol/L KCl were similar and
significantly less than the increase observed in control
vessels (Fig 3).
Responses of nonischemic vessels to cardioplegic
solution. Direct exposure of isolated vessels to K+ cold
crystalloid cardioplegic solution at 4°C increased
[Ca2+]i (Fig 4) and was associated with a small con-
traction (Fig 5). Exposure to K+ cold crystalloid car-
dioplegic solution at 37°C increased microvascular
[Ca2+]i in a similar manner (Fig 4). However, this
increase was associated with a significant contraction
of the microvessels (Fig 5). The increase in [Ca2+]i was
substantially reversible to the baseline value after
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repetitive washing with a Krebs buffer solution at 37°C
but not at 4°C (data not shown). Mg2+ cold crystalloid
cardioplegic solution induced no contraction of the
nonischemic microvessels at either 4°C or 37°C (Fig
4), nor did it increase [Ca2+]i above the baseline value
(Fig 5).
Effects of Ca2+ supplementation. The addition of
1.0 mmol/L Ca2+ to K+ cold crystalloid cardioplegic
solution at 4°C increased [Ca2+]I (Fig 6) without caus-
ing a significant contraction of the microvessels (Fig
7). At 37°C, K+ cold crystalloid cardioplegic solution
with 1.0 mmol/L Ca2+ increased [Ca2+]i similarly but in
this case was associated with a significant contraction
response of coronary microvessels (Figs 6 and 7). In
contrast, Mg2+ cold crystalloid cardioplegic solution
containing 1.0 mmol/L Ca2+ at either 4°C or 37°C
resulted in no increase in [Ca2+]i (Fig 6), probably as a
result of Ca-Mg antagonism. No contraction of the
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Fig 1. Coronary smooth muscle intracellular free calcium concentrations ([Ca2+]i) at baseline after 1 hour of car-
dioplegic infusion corresponding to ratios of fluorescence at 350 nm to that at 390 nm with fura2. K+-BCP, Cold
blood cardioplegic infusion; K+-CCP, calcium-free hyperkalemic cardioplegic infusion; Mg2+-CCP, calcium free-
hypermagnesemic cardioplegic infusion; CGI, cold global ischemia. Boxes represent mean; error bars indicate
SD; n = 6 for each group.
Fig 2. Percentage contraction of initial internal diameter of microvessels in response to application of 50 mmol/L
potassium chloride after cardioplegic infusion. K+-BCP, Cold blood cardioplegic infusion; K+-CCP, calcium-free
hyperkalemic cardioplegic infusion; Mg2+-CCP, calcium-free hypermagnesemic cardioplegic infusion; CGI, cold
global ischemia. Boxes represent mean; error bars indicate SD; n = 6 for each group.
microvessels was observed after exposure to Mg2+ cold
crystalloid cardioplegic solution with 1.0 mmol/L Ca2+
at either 4°C or 37°C (Fig 7).
Supplementation with Mg2+. Supplementation of
K+ cold crystalloid cardioplegic solution with 1.0
mmol/L Mg2+ was sufficient to inhibit the increase in
[Ca2+]i at 4°C but not at 37°C (Fig 8), suggesting that
the minimum concentration of Mg2+ required to abol-
ish the increase in [Ca2+]i is temperature dependent6
and that a small increase in magnesium supplementa-
The Journal of Thoracic and
Cardiovascular Surgery
Volume 118, Number 1
Tofukuji et al   167
Fig 3. Percentage increase from baseline of intracellular free calcium concentration ([Ca2+]i) in response to appli-
cation of 50 mmol/L potassium chloride after cardioplegic infusion. K+-BCP, Cold blood cardioplegic infusion;
K+-CCP, calcium-free hyperkalemic cardioplegic infusion; Mg2+-CCP, calcium free-hypermagnesemic cardio-
plegic infusion; CGI, cold global ischemia. Boxes represent mean; error bars indicate SD; n = 6 for each group.
Fig 4. Percentage contraction of initial internal diameter of nonischemic microvessels in response to application
of hyperkalemic crystalloid cardioplegic solution and calcium-free hypermagnesemic crystalloid cardioplegic
solution at 4°C and 37°C in nonischemic microvessels. K+-CCP, Calcium-free hyperkalemic cardioplegic solu-
tion; Mg2+-CCP, calcium free-hypermagnesemic cardioplegic solution. Boxes represent mean; error bars indicate
SD; n = 4 to 5 for each group.
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Fig 5. Increase from baseline in intracellular free calcium concentration ([Ca2+]i ) in response to application of
hyperkalemic crystalloid cardioplegic solution and hypermagnesemic crystalloid cardioplegic solution at 4°C and
37°C in nonischemic microvessels. K+-CCP, Calcium-free hyperkalemic cardioplegic solution; Mg2+-CCP, cal-
cium-free hypermagnesemic cardioplegic solution. Boxes represent mean; error bars indicate SD; n = 4 to 5 for
each group.
Fig 6. Increase from baseline in intracellular free calcium concentration ([Ca2+]i) after application of hyper-
kalemic crystalloid cardioplegic solution with 1.0 mmol/L calcium ion and hypermagnesemic crystalloid cardio-
plegic solution with 1.0 calcium ion at 4°C and 37°C in nonischemic microvessels. K+/1.0Ca2+-CCP,
Hyperkalemic cardioplegic solution containing 1.0 mmol/L calcium ion; Mg2+/1.0Ca2+-CCP, hypermagnesemic
cardioplegic solution containing 1.0 mmol/L calcium ion. Boxes represent mean; error bars indicate SD; n = 4 to
5 for each group.
tion in a hypothermic solution may be sufficient to sig-
nificantly inhibit the increase in [Ca2+]i during cardio-
plegic infusion. No significant contraction of microves-
sels was observed in response to exposure to K+ cold
crystalloid cardioplegic solution with 1.0 mmol/L
Mg2+ (–2% ± 1% at both 4°C and 37°C).
Discussion
Cold hyperkalemic crystalloid cardioplegic infusion
caused an increase in [Ca2+]i in the coronary microvas-
cular smooth muscle similar to that observed during
unprotected ischemia. Exposure of hearts to hypermag-
nesemic cardioplegic solution or the addition of Mg2+
or blood to a hyperkalemic cardioplegic solution atten-
uated the increase in microvascular [Ca2+]i during
ischemic arrest. In addition, hyperkalemic (Ca2+-free)
cardioplegic solution caused increases in [Ca2+]i at
either 4°C or 37°C, but hypothermia abolished the vas-
cular contraction associated with microvascular expo-
sure to hyperkalemia. The increase in [Ca2+]i and the
vascular contraction were also abolished when Mg2+
was added to the hyperkalemic cardioplegic solution
and were increased when Ca2+ was added to the solu-
tion. These findings have implications regarding the
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Fig 7. Percentage contraction of initial internal diameter of nonischemic microvessels after application of hyper-
kalemic crystalloid cardioplegic solution with 1.0 mmol/L calcium ion and hypermagnesemic crystalloid cardio-
plegic solution with 1.0 mmol/L calcium ion at 4°C and 37°C in nonischemic microvessels. K+/1.0Ca2+-CCP,
Hyperkalemic cardioplegic solution containing 1.0 mmol/L calcium ion; Mg2+/1.0Ca2+-CCP, hypermagnesemic
cardioplegic solution containing 1.0 mmol/L calcium ion. Boxes represent mean; error bars indicate SD; n = 4 to
5 for each group.
Fig 8. Increase from baseline in coronary smooth muscle
intracellular free calcium concentration ([Ca2+]i) in response
to application of calcium-free hyperkalemic 1.0 mmol/L
magnesium crystalloid cardioplegic solution (K+/1.0Mg2+-
CCP) at 4°C and 37°C in nonischemic microvessels. Boxes
represent mean; error bars indicate SD; n = 4 to 5 for each
group.
distribution of cardioplegic solution and the vascular
resistance during infusion. In addition, changes in
[Ca2+]i may lead to altered vascular regulation mediat-
ed through pathways dependent on calcium movements
within the cell.1,2,4
It is interesting to note that there was an apparent dis-
crepancy between the baseline [Ca2+]i and the observed
KCl–induced increases in [Ca2+]i and vascular contrac-
tions. In other words, baseline [Ca2+]i was increased,
but KCl-induced contraction and increase in [Ca2+]i
were similar in all experimental groups. Thus acute
changes in baseline vascular smooth muscle [Ca2+]i
may not significantly affect vasomotor tone or contrac-
tile responses. However, only a purely calcium-depen-
dent contractile agonist (KCl) was examined. Re-
sponses of microvessels to calcium-independent
agonists may not be preserved, and calcium-dependent
vasodilator mechanisms are known to be altered.2,4
Calcium accumulation in coronary smooth muscle
cells. Depolarization-induced Ca2+ influx through volt-
age-operated Ca2+ channels, Ca2+-induced Ca2+ release
from the sarcoplasmic reticulum, and Na+/Ca2+
exchange mechanisms are 3 major potential causes of
Ca2+ accumulation during cardioplegic infusion.
However, the exact cause of accumulation is controver-
sial and dependent on the cell type,6,7 age,8 species, and
other factors. According to the Nernst equation,9,10 the
open probability of voltage-operated Ca2+ channels is
low during hyperkalemic (25 mmol/L K+) cardioplegic
infusion, and maintained depolarization theoretically
inhibits Ca2+ influx by inactivation of L-type Ca2+
channels.11,12 However, it has been reported that the
increase in [Ca2+]i during cardioplegic infusion may be
inhibited by a calcium-channel blocker.7 A contribution
of Ca2+ in the sarcoplasmic reticulum to [Ca2+]i accu-
mulation is both probable and predicted,13 but
researchers have reported variable findings.6,7 Further-
more, increased intracellular free Na+ as a result of
Na+/H+ exchange and depolarization of the membrane
by hyperkalemic cardioplegic infusion can increase
Ca2+ influx through the Na+/Ca2+ exchange system.14
Decreased activity of the Na+/Ca2+ exchange mecha-
nism during cardioplegic infusion may theoretically
account for some of the increase in [Ca2+]i.15
In this study the cold blood cardioplegic solution used
contained less than 1.0 mmol/L Ca2+ and 0.5 mmol/L
Mg2+. This combination may cause a slight increase in
[Ca2+]i because it contains an inadequate concentration
of the Mg2+ necessary to inhibit the increase in [Ca2+]i
(Fig 8). Also, it is likely that the extracellular free Ca2+
concentration ([Ca2+]
ex
) in part determines the degree of
Ca2+ influx in response to a hyperkalemic environment.
Changes in myocardial [Ca2+]i during cardioplegic infu-
sion have been reported to be minimal in the absence of
extracellular Ca2+.8,9 In this study of vascular smooth
muscle, however, we observed an increase in [Ca2+]i
during exposure of microvessels to a Ca2+-free hyper-
kalemic solution. These findings suggest a contribution
of Ca2+ influx through release of Ca2+ from intracellular
stores (sarcoplasmic reticulum) and Ca2+-induced Ca2+
release to add to the [Ca2+]i during cardioplegic infu-
sion. A significant defect in sarcoplasmic reticulum
Ca2+ transport in the early phase of ischemia has been
reported; this is characterized by a depression of Ca2+
uptake and Ca2+ channel ATPase activity.16 The use of
Mg2+ cold crystalloid cardioplegic solution completely
abolished the increase in [Ca2+]i, possibly as a result of
Ca-Mg antagonism.
Hypothermia itself has been reported to augment the
extent of depolarization, and this may lead to increased
Ca2+ influx.17-19 Cold hyperkalemic cardioplegic infu-
sion tends to induce more [Ca2+]i overload than does
infusion of a warm (37°C) crystalloid solution.20,21 In
our study in nonischemic vessels, however, the differ-
ence in [Ca2+]i accumulation between 4°C and 37°C
during cardioplegic infusion was minimal but the
increase in [Ca2+]i remained elevated in the cytoplasm
after washing with Krebs buffer solution, suggesting
that impaired calcium mobilization may persist for a
more prolonged time.
Although the movement of Mg2+ across the sar-
colemmal membrane tends to be slow, intracellular free
Mg2+ may double within 1 to 2 seconds after a sudden
challenge with increased extracellular free Mg2+.22
Increased extracellular Mg2+ has been reported to block
Ca2+ channel currents23-25 and to act extracellularly by
inhibiting Ca2+ influx through voltage-operated Ca2+
channels and intracellularly by blocking the movement
of Ca2+ from the sarcoplasmic reticulum to the
cytosol.13,25 Mg2+ may also increase sarcoplasmic and
mitochondrial uptakes of calcium.26 In fact, both Mg2+
cardioplegic infusion and K+/Mg2+ cardioplegic infu-
sion have been reported to significantly reduce [Ca2+]i
and provide enhanced myocardial functional recovery
after ischemia.6,13,27-29
Limitations. The fact that fura 2 was loaded after
rather than before ischemic cardioplegic infusion in
isolated hearts may be a source of criticism. However,
this was the only method available to examine the
effects of blood on [Ca2+]i during blood cardioplegic
infusion. Because the data from K+– and Mg2+–cold
crystalloid cardioplegic infusion in ischemic and non-
ischemic groups were very consistent and repro-
ducible, we consider the data on blood cardioplegic
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infusion to be validated and credible. It should be noted
that measurements of [Ca2+]i and KCl-induced vascular
contraction were obtained after a period of equilibra-
tion in normothermic Krebs buffer solution and loading
of fura 2. Thus these values may be underestimates of
the actual effect in vivo.
Hypothermia (4°C) in this study decreased the fluo-
rescent ratio significantly (P = .002) by 7.3% ± 4.0%
with respect to that seen under normothermic condi-
tions (37°C), suggesting that hypothermia reduced
[Ca2+]i. In fact, calculation of the absolute [Ca2+]i at
baseline revealed that the [Ca2+]i tended to be lower at
4°C. Although a Kd value at 4°C was not examined, the
Kd value at 37°C according to the report by Pawlowski
and associates30 would be expected and was therefore
used in this study. R
max
(0.983 ± 0.009 at 4°C and 1.015
± 0.038 at 37°C) and R
min (0.412 ± 0.010 at 4°C and
0.417 ± 0.024 at 37°C) were not significantly different
between 4°C and 37°C, but the S value at 4°C (1.11 ±
0.07) was significantly (P = .002) lower than that at
37°C (1.65 ± 0.19). This finding suggests that, contrary
to the previous reports,17-19 hypothermia itself may
decrease [Ca2+]i. However, further examination is
required to verify this speculation.
Conclusions
Cold hyperkalemic cardioplegic infusion led to an
increase in [Ca2+]i in the coronary vascular smooth
muscle similar to that observed during cold unprotect-
ed ischemia. The addition of Mg2+ to the hyperkalemic
solution and the use of a blood-based or Mg2+-based
cardioplegic solution both markedly reduced this
increase in [Ca2+]i. Such solutions may better protect
the coronary circulation during ischemic arrest.
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